Logos Capital is a fundamental biotechnology-focused investment partnership that combines scientific and financial expertise with in-house clinical trial analytics to identify transformative therapies in healthcare. Based in San Francisco, Logos combines expertise across medical, scientific, and statistical disciplines to expand the depth of diligence in identifying compelling investment themes and opportunities.
Our mission is to build a world-class biotechnology investment partnership, focused on generating superior long-term returns for our investors and financing innovation that will meaningfully advance the standard of care for patients
People
- Dr Arsani William, Managing Partner
You last contacted this investor on .